Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population

NCT02209168 — Withdrawn, IVI Madrid

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Differences in Ovarian Reserve Markers, Vitamin D Serum Levels and Reproductive Outcomes Between Infertile Indian, Arabian and Caucasian Population

RegistryNCT02209168
StatusWithdrawn
Study typeObservational
SponsorIVI Madrid (Other)
ConditionsFemale Infertility Due to Diminished Ovarian Reserve, Vitamin D Deficiency, Hormone Deficiency, Follicular Cyst of Ovary
Datesstart 2015-11-01, primary completion 2018-12-01 (estimated), completion 2019-03-01 (estimated), first posted 2014-08-05, last updated 2018-09-04
Locations1 site in Spain

Related Papers Related Patents Related Grants Related Experts
All trials for Female Infertility Due to Diminished Ovarian Reserve All trials for Vitamin D Deficiency

-Summary

The aim of this study is to confirm the difference in ovarian reserve markers and serum vitamine D levels between infertile indian, arabian and caucasian population.

Expand all sections  ·  Collapse all

+Detailed description

200 caucasian, indian, and arab patients

+Arms and interventions

ArmTypeInterventionsDescription
Infertile Indian Population200 Infertile Indian population
Infertile arabian population200 Infertile Arabian population
Infertile caucasian population200 Infertile Caucasian population

+Outcome measures

Primary outcomes

  • Ovarian reserve markers: antimullerian hormone, FSH, antral follicle count [beginning of the treatment cycle]

Secondary outcomes

  • Serum vitamin D levels [Beginning of their treatment cycle]

+Eligibility

Sex: Female, ages: 21 Years to 43 Years, accepts healthy volunteers

Inclusion Criteria:

WOMEN BETWEEN 21-43 YEARS FIRST OR SECOND IN VITRO FERILIZATION TREATMENT DUE TO TUBAL, MASCULINE OR PREVIOUS INTRAUTERINE INSEMINATION FAIL TREATMENT

Exclusion Criteria:

POLYCYSTIC PATIENTS ENDOMETRIOSIS GRADE III OR IV INFLAMMATORY PELVIC DISEASE

+Locations (1)

FacilityCityCountryStatus
IVI MadridMadridSpain

+Investigators

  • CARLOS IGLESIAS, MD, Principal investigator, IVI Madrid